Being Fitter May Help Your Kidneys Age More Slowly, New Study Finds
A tiny wearable that claims to track blood flow to your brain has become one of the most debated fitness gadgets of the year — and doctors are not convinced it can do what it promises.
Temple, a device created by Zomato and Eternal co-founder Deepinder Goyal, is a small oval sensor worn on the side of the forehead, near the temple. It weighs under 2 grams and is less than an inch wide. Its makers say its "BrainFlow" feature shows how well the brain is being supplied with blood in real time, while a second metric, "Entropy," is designed to measure how hard the body is working to maintain itself. Promotional materials also say it can track thermal, immune, digestive, cognitive and emotional readings.
The device opened for pre-orders in India on November 1 at ₹85,000 — roughly $900 to $950 — with shipments expected to begin in early 2027. Indian cricket captain Shubman Gill and badminton star PV Sindhu have been spotted wearing it.
But a growing number of doctors say the science does not add up. The central objection is anatomical: Temple's optical sensors sit over the superficial temporal artery, which supplies blood to the scalp and face — not the brain, which is fed mainly by the internal carotid and vertebral arteries. "We cannot assume that the readings from this artery accurately reflect blood flow through the arteries supplying the brain," senior neurologist Dr. Sudhir Kumar of Apollo Hospitals wrote on X.
Hepatologist Dr. Cyriac Abby Philips, known online as "TheLiverDoc," has called Temple "the biggest health scam," arguing its claims are not backed by peer-reviewed research. Neurologist Dr. Praveen Gupta told Times Now that there is not enough independent research to show the sensor can separate signals from the brain from those coming from the scalp, and that no large peer-reviewed studies exist beyond the company's own data.
Goyal has pushed back, insisting Temple is a fitness and AI product — not a medical device. "We didn't make any medical claim," he wrote on X. "Temple is strictly a fitness + AI device, and we've made no medical claims. Temple is not proven to diagnose or prevent any disease." He said the company is preparing preprints of its research, with peer-reviewed studies to follow, and that BrainFlow is no longer the device's main focus — Entropy is.
For now, the dispute is a reminder for anyone shopping for health tech: a bold claim on a product page is not the same as proven science. Before spending hundreds of dollars on a device that promises to read your brain, check whether independent, peer-reviewed evidence backs it up.
Sources: The Financial Express, Business Standard, The Straits Times, The Economic Times
Photo: The CSR Journal
Comments
Post a Comment